Product Overview

i-spero® is a new personalised medicine approach to improve the treatment of depression within primary care.

Optimising the depression treatment pathway

Sufferers with low mood, depression and anxiety who present in primary care are given access to i‑spero® to complete a simple set of pre-assessments online (P1vital® PReDicT Test — CE marked medical device).

Monitor progress

i‑spero® monitors progress against a personal care plan and sends reminders when actions and scheduled symptom monitoring assessments are due.

Review outcomes

i‑spero® reviews outcomes against a personal care plan and alerts the patient to take action when needed. The healthcare provider also monitors i‑spero® results, alerts and notifications, and can contact the patient in order to discuss recommended changes to their care plan .

Monitor outcome assessments

i‑spero® monitors symptom assessment outcomes on an ongoing basis through to recovery, and can be used to record any care plan changes.

Don't just take our word for it

i-spero® helps clinicians to make switches in medication

In recent trials i‑spero® increased the frequency that clinicians switched medication significantly and for all age groups.

i-spero® helps improve compliance with treatment

What I value about i‑spero® is that I can improve the quality of care for my patients. Depression is a huge problem in primary care and proven innovations that can improve outcomes for suffers is to be welcomed.

Patients find the online tests easy to use at home

Over 85% agree that the tests are ‘easy to use’ and over 70% found no technical or connectivity problems when taking the test.

Find out how i-spero® can help your patients

If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.